Summary & Overview
HCPCS Level II J2404: Nicardipine Injection, 0.1 mg
HCPCS Level II code J2404 identifies a billed unit for nicardipine injection at 0.1 mg. Nicardipine is a calcium channel blocker used for acute blood pressure control and other short-term intravenous indications; capturing its use with a specific HCPCS code enables standardized claims processing and national tracking of medication utilization and costs. This code matters nationally for hospital and outpatient infusion billing, formulary management, and acute-care drug spending.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how J2404 maps to parenteral nicardipine administration, common sites of service where the drug is used, and typical billing considerations. The publication also summarizes available nationwide benchmarks for utilization and reimbursement patterns, notable policy updates affecting HCPCS drug coding and billing, and clinical context relevant to acute antihypertensive therapy.
The report is intended for revenue cycle leaders, hospital pharmacists, coding professionals, and policy analysts who need concise guidance on coding practice, payer coverage landscape, and where J2404 fits within broader drug billing and utilization frameworks. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J2404 represents an injection of nicardipine, 0.1 mg. This code describes the drug product and dosing unit for intravenous or other parenteral administration when nicardipine is provided as a billed medication.
-
Service type: Drug administration (parenteral medication)
-
Typical site of service: Hospital inpatient, hospital outpatient infusion centers, emergency departments, and other settings where parenteral antihypertensive therapy is administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized with an acute hypertensive emergency or severe postoperative hypertension requiring intravenous arterial vasodilation. The patient may present to the emergency department or intensive care unit with markedly elevated blood pressure and signs of end-organ dysfunction (e.g., acute pulmonary edema, hypertensive encephalopathy) where rapid titratable blood pressure control is needed. Nicardipine injection J2404 (0.1 mg per unit) is administered via continuous IV infusion or intermittent IV bolus in a monitored setting by critical care, emergency medicine, or anesthesia teams. The clinical workflow includes emergency evaluation, placement of IV access (often a central line for prolonged infusion), baseline labs and monitoring, initiation and titration of nicardipine infusion with frequent blood pressure checks, adjustment based on response, and documentation of dose, units billed, start/stop times, and indication. Pharmacy prepares the injection per institutional concentration protocols, and nursing documents vital signs and infusion rates. Billing uses J2404 units corresponding to the billed dose; medical records must support the necessity, dose, and duration. Common concurrent services include sedation or analgesia for intubation, ventilator support, hemodynamic monitoring, and orders for serial labs and imaging as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |